-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ATRN-119 in Colon Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ATRN-119 in Colon Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ATRN-119 in Colon Cancer Drug Details: ATRN-119 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Durvalumab in Metastatic Breast Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Durvalumab in Metastatic Breast Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Durvalumab in Metastatic Breast Cancer Drug Details: Durvalumab (MEDI-4736, Imfinzi,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ND-10 ER in Myopia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ND-10 ER in Myopia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ND-10 ER in Myopia Drug Details: ND-10 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ND-0612 in Parkinson’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ND-0612 in Parkinson's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ND-0612 in Parkinson's Disease Drug Details: ND-0612 is under development as...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NZV-930 in Pancreatic Ductal Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NZV-930 in Pancreatic Ductal Adenocarcinoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NZV-930 in Pancreatic Ductal Adenocarcinoma Drug Details: NZV-930 is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Cabiralizumab in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Cabiralizumab in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Cabiralizumab in Melanoma Drug Details: Cabiralizumab (CSF1R antibody) is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Batoprotafib in Esophageal Squamous Cell Carcinoma (ESCC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Batoprotafib in Esophageal Squamous Cell Carcinoma (ESCC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Batoprotafib in Esophageal Squamous Cell Carcinoma (ESCC) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Thymalfasin in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Thymalfasin in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Thymalfasin in Solid Tumor Drug Details: Thymalfasin (Zadaxin) is a synthetic...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Secukinumab in Tendon and Ligament Pain
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. Secukinumab in Tendon and Ligament Pain Drug Details: Secukinumab (Cosentyx, Zafrez, Fraizeron, Scapho Lyvi) is...
-
Product Insights
PrairieWinds ND 1
PrairieWinds ND 1 is an Onshore Wind project located in North Dakota, United States. The project is owned and developed by Basin Electric Power Coop. The project came online in 2009. Empower your strategies with our PrairieWinds ND 1 report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...